Groupama Asset Managment lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 0.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 502,609 shares of the biotechnology company's stock after purchasing an additional 1,349 shares during the period. Groupama Asset Managment owned 0.65% of Axon Enterprise worth $2,581,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise during the fourth quarter valued at about $30,000. TCTC Holdings LLC grew its position in Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after buying an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC grew its position in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after buying an additional 33 shares during the period. Catalyst Capital Advisors LLC bought a new position in Axon Enterprise during the first quarter valued at about $32,000. Finally, Alpine Bank Wealth Management bought a new position in Axon Enterprise during the first quarter valued at about $40,000. Institutional investors own 79.08% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the company. Wolfe Research initiated coverage on Axon Enterprise in a research note on Monday, July 7th. They issued an "outperform" rating on the stock. Bank of America raised their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Barclays raised their target price on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the stock an "overweight" rating in a research note on Friday, July 11th. Finally, Needham & Company LLC set a $870.00 target price on Axon Enterprise and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Thirteen equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and an average price target of $837.69.
View Our Latest Research Report on AXON
Axon Enterprise Trading Up 0.4%
Shares of NASDAQ AXON traded up $2.73 during midday trading on Friday, reaching $766.24. The company had a trading volume of 395,415 shares, compared to its average volume of 739,771. Axon Enterprise, Inc has a one year low of $346.71 and a one year high of $885.91. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The firm's fifty day moving average price is $773.05 and its 200-day moving average price is $674.00. The stock has a market cap of $60.15 billion, a PE ratio of 189.20, a price-to-earnings-growth ratio of 28.12 and a beta of 1.36.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same period in the prior year, the firm posted $1.20 earnings per share. The company's quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the completion of the sale, the chief executive officer directly owned 3,053,982 shares in the company, valued at $2,538,744,696.78. This trade represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, President Joshua Isner sold 15,919 shares of the firm's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the sale, the president owned 238,379 shares of the company's stock, valued at $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,790 shares of company stock worth $33,654,451 over the last 90 days. 4.40% of the stock is owned by insiders.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.